Global Darunavir Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Darunavir Market Overview
- 1.1 Product Overview and Scope of Darunavir
- 1.2 Classification of Darunavir by Types
- 1.2.1 Global Darunavir Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Darunavir Revenue Market Share by Types in 2018
- 1.2.3 Tablet
- 1.2.4 Oral suspension
- 1.3 Global Darunavir Market by Application
- 1.3.1 Global Darunavir Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Global Darunavir Market by Regions
- 1.4.1 Global Darunavir Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Darunavir Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Darunavir Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Darunavir Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Darunavir Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Darunavir Status and Prospect (2014-2024)
- 1.5 Global Market Size of Darunavir (2014-2024)
2 Manufacturers Profiles
- 2.1 Janssen Therapeutics
- 2.1.1 Business Overview
- 2.1.2 Darunavir Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Janssen Therapeutics Darunavir Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Mylan
- 2.2.1 Business Overview
- 2.2.2 Darunavir Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Mylan Darunavir Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Teva
- 2.3.1 Business Overview
- 2.3.2 Darunavir Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Teva Darunavir Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Cipla
- 2.4.1 Business Overview
- 2.4.2 Darunavir Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Cipla Darunavir Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Lupin
- 2.5.1 Business Overview
- 2.5.2 Darunavir Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Lupin Darunavir Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Hetero
- 2.6.1 Business Overview
- 2.6.2 Darunavir Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Hetero Darunavir Revenue, Gross Margin and Market Share (2017-2018)
3 Global Darunavir Market Competition, by Players
- 3.1 Global Darunavir Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Darunavir Players Market Share
- 3.2.2 Top 10 Darunavir Players Market Share
- 3.3 Market Competition Trend
4 Global Darunavir Market Size by Regions
- 4.1 Global Darunavir Revenue and Market Share by Regions
- 4.2 North America Darunavir Revenue and Growth Rate (2014-2019)
- 4.3 Europe Darunavir Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Darunavir Revenue and Growth Rate (2014-2019)
- 4.5 South America Darunavir Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Darunavir Revenue and Growth Rate (2014-2019)
5 North America Darunavir Revenue by Countries
- 5.1 North America Darunavir Revenue by Countries (2014-2019)
- 5.2 USA Darunavir Revenue and Growth Rate (2014-2019)
- 5.3 Canada Darunavir Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Darunavir Revenue and Growth Rate (2014-2019)
6 Europe Darunavir Revenue by Countries
- 6.1 Europe Darunavir Revenue by Countries (2014-2019)
- 6.2 Germany Darunavir Revenue and Growth Rate (2014-2019)
- 6.3 UK Darunavir Revenue and Growth Rate (2014-2019)
- 6.4 France Darunavir Revenue and Growth Rate (2014-2019)
- 6.5 Russia Darunavir Revenue and Growth Rate (2014-2019)
- 6.6 Italy Darunavir Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Darunavir Revenue by Countries
- 7.1 Asia-Pacific Darunavir Revenue by Countries (2014-2019)
- 7.2 China Darunavir Revenue and Growth Rate (2014-2019)
- 7.3 Japan Darunavir Revenue and Growth Rate (2014-2019)
- 7.4 Korea Darunavir Revenue and Growth Rate (2014-2019)
- 7.5 India Darunavir Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Darunavir Revenue and Growth Rate (2014-2019)
8 South America Darunavir Revenue by Countries
- 8.1 South America Darunavir Revenue by Countries (2014-2019)
- 8.2 Brazil Darunavir Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Darunavir Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Darunavir Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Darunavir by Countries
- 9.1 Middle East and Africa Darunavir Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Darunavir Revenue and Growth Rate (2014-2019)
- 9.3 UAE Darunavir Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Darunavir Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Darunavir Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Darunavir Revenue and Growth Rate (2014-2019)
10 Global Darunavir Market Segment by Type
- 10.1 Global Darunavir Revenue and Market Share by Type (2014-2019)
- 10.2 Global Darunavir Market Forecast by Type (2019-2024)
- 10.3 Tablet Revenue Growth Rate (2014-2024)
- 10.4 Oral suspension Revenue Growth Rate (2014-2024)
11 Global Darunavir Market Segment by Application
- 11.1 Global Darunavir Revenue Market Share by Application (2014-2019)
- 11.2 Darunavir Market Forecast by Application (2019-2024)
- 11.3 Hospital Revenue Growth (2014-2019)
- 11.4 Drug store Revenue Growth (2014-2019)
12 Global Darunavir Market Size Forecast (2019-2024)
- 12.1 Global Darunavir Market Size Forecast (2019-2024)
- 12.2 Global Darunavir Market Forecast by Regions (2019-2024)
- 12.3 North America Darunavir Revenue Market Forecast (2019-2024)
- 12.4 Europe Darunavir Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Darunavir Revenue Market Forecast (2019-2024)
- 12.6 South America Darunavir Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Darunavir Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
Scope of the Report:
The global Darunavir market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Darunavir.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Darunavir market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Darunavir market by product type and applications/end industries.
Market Segment by Companies, this report covers
Janssen Therapeutics
Mylan
Teva
Cipla
Lupin
Hetero
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablet
Oral suspension
Market Segment by Applications, can be divided into
Hospital
Drug store